On Thursday, Delek US Holdings, Inc. (NYSE:DK)’s shares inclined 0.30% to $36.88.
Delek US Holdings, Inc. (DK) declared that the Company intends to issue a press release summarizing second quarter 2015 results after the U.S. stock market closes on Monday, August 3, 2015. A conference call to talk about second quarter 2015 results is planned to start at 11:30 a.m. CT (12:30 p.m. ET) on Tuesday, August 4, 2015.
Delek US Holdings, Inc. operates as an integrated downstream energy company that operates in petroleum refining, wholesale distribution, and convenience store retailing businesses. The company operates in three segments: Refining, Logistics, and Retail. The Refining segment owns and operates two refineries in Tyler, Texas, and El Dorado, Arkansas; and produces various petroleum-based products used in transportation and industrial markets.
TherapeuticsMD Inc (NYSEMKT:TXMD)’s shares gained 3.41% to $8.50.
TherapeuticsMD Inc (TXMD) declared the pricing of an underwritten public offering of about 3.8 million shares of its common stock, offered at a price of $7.80 per share. The gross proceeds to TherapeuticsMD from this offering are predictable to be about $30.0 million, before deducting underwriting discounts, commissions and other offering expenses payable by TherapeuticsMD. In addition, TherapeuticsMD has granted the underwriters an option for a period of 30 days to purchase, at the public offering price less the underwriting discount, up to about 577,000 additional shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is predictable to close on or about July 15, 2015, subject to the satisfaction of customary closing conditions.
TherapeuticsMD, Inc. operates as a woman’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, counting prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, in addition to duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name.
At the end of Thursday’s trade, Core Laboratories N.V. (NYSE:CLB)‘s shares surged 8.42% to $108.43.
Core Laboratories N.V. (CLB) stated second quarter 2015 earnings per diluted share (“EPS”) of $0.82, not taking into account foreign exchange translations not comprised of in earlier guidance (“ex-item”), which are referenced in the non-GAAP reconciliation comprised of in this release. Revenue for the second quarter was $204,000,000, down 4.6% sequentially from first quarter 2015 levels, however, operating margins were up sequentially by 30 basis points to 24% creating strong incremental margins. The Company’s preceding guidance called for operating margins to bottom in the first quarter and revenue to bottom in the second quarter; and Core’s results this quarter confirmed that view. Second quarter 2015 net income, ex-item, totaled $35,400,000. Additionally, year-over-year second quarter revenue was negatively affected by about $8,000,000, or 4%, in foreign currency exchange rate changes as compared to the U.S. dollar.
Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir administration services to the oil and gas industry in the United States, Canada, and internationally. The company’s Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples.
Eastman Chemical Company (NYSE:EMN), ended its Thursday’s trading session with -1.56% loss, and closed at $74.52.
Eastman Chemical Company (EMN) declared LLumar has been named the official window tint and paint protection film of West Coast Customs, the world famous premiere vehicle customization shop internationally known for extraordinary builds, celebrity clients and the hit television show, West Coast Customs on the Fox Sports 2 Network. All custom builds in Season Three will feature LLumar window tint.
Eastman Chemical Company, a specialty chemical company, manufactures and sells materials, chemicals, and fibers in the United States and internationally. The company’s Additives & Functional Products segment offers solvents, such as specialty coalescents and ketones and esters, glycol ethers, and alcohol solvents; cellulose and polyester-based specialty polymers, and paint additives; insoluble sulfur products; antidegradants; hydrocarbon resins; specialty intermediates, performance products, and formic acid; and alkylamine derivatives.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
